The Federal Trade Commission (FTC) continues to prioritize consumer protection, taking significant steps to eliminate fraud and imposter scams. Additionally, the FTC issued a final consent order against a U.S. pest-control company to end its noncompete agreements with tens of thousands of its employees. The FTC also filed an amicus brief alleging that a major drug manufacturer maintained an illegal monopoly in the market for a drug used to treat several autoimmune conditions. These stories and more, after the jump.

The Federal Trade Commission (FTC) closed out April and opened May with activity across both consumer protection and competition bureaus. This past week, the agency released new data showing the scale of social media-driven fraud, targeted allegedly deceptive multi-level marketing earnings claims, urged the Tennessee Supreme Court to reduce its reliance on ABA law school accreditation, and required divestitures to resolve competition concerns in a foodservice technology merger. More on these stories after the jump.

This week, the Federal Trade Commission (FTC) announced that a company’s president and CEO must pay a $140 million judgment based on participation in a timeshare exit scheme. The FTC also took action that backed Chairman Ferguson’s prioritization of healthcare fraud with the establishment of a Healthcare Task Force in March. More on these stories after the jump.

The FTC has been active across both consumer protection and competition spaces in the past two weeks. In the consumer protection space, the agency announced several proposed settlements with companies and individuals, resolving complaints of alleged deceptive marketing, consumer privacy violations, and false advertising. In the competition space, the FTC and DOJ’s Antitrust Division launched a joint public inquiry into the effectiveness of the updated HSR premerger notification form. Operationally, the FTC was also engaged on several fronts, including testifying before the Joint Economic Committee, submitting its FY 2027 budget request to Congress, and announcing its five-year strategic plan. These stories and more after the jump.

The FTC has been busy sending money to consumers harmed by unfair or deceptive business acts or practices. The Commission has also announced a settlement with healthcare companies related to the cost of insulin drugs and released a recent report regarding it focus on privacy and cybersecurity. More on this news after the jump.

As we enter the new year, the FTC continues to prioritize consumer protection and fair competition, taking significant steps to prosecute offenders for alleged misleading conduct regarding consumer consent and enforce existing court orders. Additionally, the FTC has announced multiple revisions to the jurisdictional thresholds under the Clayton Act, increasing the thresholds for premerger notification filings, related filing fees, and interlocking directorates. Finally, Commissioner Meador delivered the keynote address at the 2026 Tech Antitrust Conference and discussed concerns about technology innovation and the emerging trend of “acqui-hires.” These stories and more after the jump.